New on vaccine checklist: Pneumonia shot for ages 50 and up
NEW YORK — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause ...
MedPage Today8h
ACIP Votes to 'Harmonize' Dosing and Interval for Meningococcal B Vaccines
In a 15-0 vote, ACIP recommended that MenB-4C be administered as a two-dose series at 0 and 6 months when given to healthy ...
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
The CDC recommends expanding pneumococcal vaccine eligibility to adults aged 50 and above, impacting disease prevention with Pfizer and Merck's vaccines.
US CDC AdCom recommends lowering the age for pneumococcal vaccines
The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’s Prevnar 20 to 50 years down from 65.
FiercePharma15h
Moderna mounts campaign to tackle low awareness of vaccine eligibility
Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...
FiercePharma16h
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...